UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop

BMC health services research, 2021-05, Vol.21 (1), p.412-412, Article 412

2021

Link zum Volltext

Verfügbarkeit prüfen

Indication-specific pricing of pharmaceuticals in the US healthcare system

Journal of comparative effectiveness research, 2017-07, Vol.6 (5), p.397-404

2017

Link zum Volltext

Verfügbarkeit prüfen

How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice

Health research policy and systems, 2015-01, Vol.13 (1), p.1-1, Article 1

2015

Link zum Volltext

Verfügbarkeit prüfen

Not cost-effective at zero price: valuing and paying for combination therapies in cancer

Expert review of pharmacoeconomics & outcomes research, 2021-05, Vol.21 (3), p.331-333

2021

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy: evidence, value and affordability in the US health care system

Journal of comparative effectiveness research, 2018-01, Vol.7 (1), p.15-28

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world evidence for coverage decisions: opportunities and challenges

Journal of comparative effectiveness research, 2018-12, Vol.7 (12), p.1133-1143

2018

Link zum Volltext

Verfügbarkeit prüfen

The impact of Payback research: developing and using evidence in policy

Research evaluation, 2011-09, Vol.20 (3), p.257-258

Henshall, Chris

2011

Link zum Volltext

Verfügbarkeit prüfen

OP03 Optimizing The Use Of RWE In HTA: Lessons From The ICER Summit

International journal of technology assessment in health care, 2018, Vol.34 (S1), p.1-2

2018

Link zum Volltext

Verfügbarkeit prüfen

VP87 Extrapolation From Progression Free Survival To Overall Survival In Oncology

International journal of technology assessment in health care, 2017, Vol.33 (S1), p.188-189

2017

Link zum Volltext

Verfügbarkeit prüfen

Cornerstones of ‘fair’ drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals

Journal of comparative effectiveness research, 2021-05, Vol.10 (7), p.537-547

2021

Link zum Volltext

Verfügbarkeit prüfen

CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?-ERRATUM

International journal of technology assessment in health care, 2016-01, Vol.32 (6), p.407-407

2016

Link zum Volltext

Verfügbarkeit prüfen

Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit

Journal of comparative effectiveness research, 2019-10, Vol.8 (13), p.1045-1054

2019

Link zum Volltext

Verfügbarkeit prüfen

A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions

Journal of comparative effectiveness research, 2018-12, Vol.7 (12), p.1145-1152

2018

Link zum Volltext

Verfügbarkeit prüfen

INTERACTION INITIATIVES BETWEEN REGULATORY, HEALTH TECHNOLOGY ASSESSMENT AND COVERAGE BODIES, AND INDUSTRY

International journal of technology assessment in health care, 2012-10, Vol.28 (4), p.374-381

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

ClinicoEconomics and outcomes research, 2016-01, Vol.8, p.427-433

2016

Link zum Volltext

Verfügbarkeit prüfen

Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?

Therapeutic innovation & regulatory science, 2014-05, Vol.48 (3), p.341-346

2014

Link zum Volltext

Verfügbarkeit prüfen

Procurement change in Canada: An opportunity for improving system performance

Healthcare management forum, 2012, Vol.25 (2), p.66-69

2012

Link zum Volltext

Verfügbarkeit prüfen

Towards a coordinated approach for managing accelerated patient access to potentially beneficial medicines: reporting the perspectives of a multi-stakeholder, international workshop

Health affairs scholar, 2024-06, Vol.2 (6), p.qxae069-qxae069

2024

Link zum Volltext

Verfügbarkeit prüfen

Executive summary of the ECHTA/ECAHI project : European Collaboration for Health Technology Assessment: Developing an Assessment Network

International journal of technology assessment in health care, 2002, Vol.18 (2), p.213-217

2002

Link zum Volltext

Verfügbarkeit prüfen

Summary report of the ECHTA/ECAHI project : European Collaboration for Health Technology Assessment: Developing an Assessment Network

International journal of technology assessment in health care, 2002, Vol.18 (2), p.218-237

2002

Link zum Volltext

Verfügbarkeit prüfen

Summary report of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions

International journal of technology assessment in health care, 2002, Vol.18 (2), p.218-237

2002

Link zum Volltext

Verfügbarkeit prüfen

Executive summary of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions

International journal of technology assessment in health care, 2002, Vol.18 (2), p.213-217

2002

Link zum Volltext

Verfügbarkeit prüfen

HEALTH TECHNOLOGY ASSESSMENT IN POLICY AND PRACTICE

International journal of technology assessment in health care, 2002-04, Vol.18 (2), p.447-455

2002

Link zum Volltext

Verfügbarkeit prüfen

Health technology assessment in policy and practice: working group 6 report : European Collaboration for Health Technology Assessment: Developing an Assessment Network

International journal of technology assessment in health care, 2002, Vol.18 (2), p.447-455

2002

Link zum Volltext

Verfügbarkeit prüfen

Microvascular stabilization via blood-brain barrier regulation prevents seizure activity

Nature communications, 2022-04, Vol.13 (1), p.2003-2003, Article 2003

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionEmerald Management 200

Zeitschrift / SerieEconomic Geography

Zeitschrift / SerieEuropean Journal Of Epidemiology

ThemaPublic, Environmental & Occupational Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(35)
Tagungsberichte
(2)

Sprache

Englisch
(37)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop

Indication-specific pricing of pharmaceuticals in the US healthcare system

How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice

Not cost-effective at zero price: valuing and paying for combination therapies in cancer

Gene therapy: evidence, value and affordability in the US health care system

Real-world evidence for coverage decisions: opportunities and challenges

The impact of Payback research: developing and using evidence in policy

OP03 Optimizing The Use Of RWE In HTA: Lessons From The ICER Summit

VP87 Extrapolation From Progression Free Survival To Overall Survival In Oncology

Cornerstones of ‘fair’ drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals

CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?-ERRATUM

Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit

A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions

INTERACTION INITIATIVES BETWEEN REGULATORY, HEALTH TECHNOLOGY ASSESSMENT AND COVERAGE BODIES, AND INDUSTRY

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?

Procurement change in Canada: An opportunity for improving system performance

Towards a coordinated approach for managing accelerated patient access to potentially beneficial medicines: reporting the perspectives of a multi-stakeholder, international workshop

Executive summary of the ECHTA/ECAHI project : European Collaboration for Health Technology Assessment: Developing an Assessment Network

Summary report of the ECHTA/ECAHI project : European Collaboration for Health Technology Assessment: Developing an Assessment Network

Summary report of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions

Executive summary of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions

HEALTH TECHNOLOGY ASSESSMENT IN POLICY AND PRACTICE

Health technology assessment in policy and practice: working group 6 report : European Collaboration for Health Technology Assessment: Developing an Assessment Network

Microvascular stabilization via blood-brain barrier regulation prevents seizure activity

Aktive Filter

Suchergebnisse filtern